In summary, our data provide the first evidence that overexpression of CARP decreases the activity of both the ERK1/2 and the TGF-β/Smads signaling pathways and subsequently attenuates cardiac hypertrophy and fibrosis in the hearts of CARP transgenic mice (Figure S6). The gene discussed is MAPK3; the disease is cardiac hypertrophy.